Studies cast doubt on migraine-relief surgery

07/1/2014 | HealthDay News

Two studies on migraine trigger deactivation surgery had flawed study methods, and the surgery is expensive and risky, according to an analysis presented at the American Headache Society's annual meeting. Some patients experience lingering itchiness and numbness after the surgery, researchers said. The treatment should be studied further and appears to work for some patients, but it should not be marketed as a cure, the team said.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
Actuary
Meridian Health Plan
Detroit, MI
Chief Financial Officer
B. E. Smith
Miramar, FL